IBO
Impact Biomedical
$3.99
+$0.44 (+12.39%)Oct 28, 2026
Key metrics
The numbers that frame IBO today
- Market cap
- $430.21M
- Gross margin
- -1,111.4%
- EV / Sales
- 12,291.3
- ROIC
- 160.4%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $0.37
- 52wk High
- $7.11
Growth
Revenue and earnings trend for IBO
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about IBO
Is Impact Biomedical a good buy?
Hold. Impact Biomedical has excellent momentum, but poor quality makes the setup mixed. Growth looks excellent, which supports the long-term business case, but quality and momentum do not clear the bar together. We think Impact Biomedical is selling at a high price.
What is the market capitalization of IBO?
Impact Biomedical's market capitalization is $430.21M.
What is the 52-week high for IBO stock?
The 52-week high for Impact Biomedical is $7.11. The current close of $3.99 is 43.9% below that high.
What is the 52-week low for IBO stock?
The 52-week low for Impact Biomedical is $0.37. The current close of $3.99 is 978.4% above that low.
Does IBO stock pay dividends?
Impact Biomedical does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for IBO?
Impact Biomedical's Debt / Equity ratio is 0.